A recent study spanning three decades examines the global burden of tracheal, bronchial, and lung (TBL) cancer among individuals aged 70 years and above.
The analysis reveals increasing incidence rates, mortality rates, and disability-adjusted life years associated with TBL cancers in the elderly demographic, driven by population aging and growth.
Precision medicine breakthroughs have shown declines in cancer incidence and mortality among males but an increase in burden among females aged 70 and above.
Geographical variation shows rising TBL cancer incidence in middle-SDI regions, East Asia, and western sub-Saharan Africa, while high-SDI regions exhibit declining trends.
Smoking remains a primary cause of TBL cancers globally, alongside emerging concerns regarding environmental pollution's impact on respiratory health.
Projections suggest a decline in incidence and mortality rates among males and the elderly population over the next fourteen years but persistence or increase among females.
Precision medicine faces barriers in resource-limited settings and among older populations, necessitating equitable distribution of innovation and personalized care plans.
Occupational exposures, air pollution, and lifestyle factors beyond smoking play significant roles in modulating lung cancer risk and disease progression.
Multidisciplinary approaches and subgroup-specific management strategies are essential for improving outcomes in older adults with TBL cancers.
Addressing barriers requires policy initiatives, expanded environmental health programs, improved screening accessibility, and inclusive clinical trials.